Table 2.
SIB |
BPT |
|||
---|---|---|---|---|
Variable | Est. odds ratio (95% CI) | p-value | Est. odds ratio (95% CI) | p-value |
Baseline age (years) | 1.12 (0.98, 1.29) | 0.104 | 1.10 (0.96, 1.26) | 0.154 |
Female | 0.52 (0.14, 1.89) | 0.321 | 0.52 (0.15, 1.79) | 0.297 |
APOE4 | 1.50 (0.36, 6.30) | 0.582 | 0.50 (0.11, 2.29) | 0.373 |
Pre-morbid cognitive impairment: Severe or profound | 0.56 (0.00, 502.66) | 0.869 | 0.62 (0.00, 373.09) | 0.882 |
Treatment group (antioxidant vs. placebo) | 4.61 (1.22, 17.35) | 0.024 | 2.70 (0.68, 10.75) | 0.160 |
Baseline DMR SC score (pre-morbid CI: not severe or profound) | 1.10 (1.00, 1.21) | 0.041 | 1.04 (0.95, 1.14) | 0.358 |
Baseline DMR SC score (pre-morbid CI: severe or profound) | 1.08 (0.88, 1.32) | 0.477 | 1.05 (0.87, 1.27) | 0.621 |
Years since dementia onset at baseline | 1.42 (0.94, 2.15) | 0.099 | 1.36 (0.91, 2.03) | 0.138 |
Seizure status (yes vs. no) | 11.02 (1.59, 76.27) | 0.015 | 9.02 (1.90, 42.85) | 0.006 |
Point estimates are reported on the odds ratio scale of the conditional probability of inability to test at a particular time given the subject is at risk at that particular time. Regression estimates are adjusted for all variable listed in the table. CI-Cognitive impairment.